Opens in a new tab or window The FDA designated Abbott's recall of FreeStyle Libre 3 sensors as the most ... pump for all adults with type 1 and 2 diabetes. The agency also cleared Embecta's ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

The FDA designated Abbott's recall of FreeStyle Libre 3 sensors as the most serious ... insulin patch pump for all adults ...

A parenting expert has given five top tips to help parents adjust to a quieter household as millions of students prepare to ...

DexCom's newest G7 CGM competes closely with Abbott's FreeStyle ... MARD around 8.2% for G7. Wearable for 10.5 days and water-resistant up to 8ft for 24 hours. - Abbott Libre (Libre 2 and Libre ...

The FreeStyle Libre 3 system consists of the sensor around the size of a £1 coin that is worn on the upper arm and an app which can be used by users to record their real-time glucose levels and ...

In the second quarter, Abbott incurred a 2.7% increase in the ... growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre. In a relatively short span ...

Abbott is working to integrate its newest continuous glucose monitor (CGM) with Beta Bionics’ automated insulin delivery (AID) system. The companies plan to connect Beta Bionics’ iLet Bionic Pancreas ...

Foreign exchange fluctuation is a major headwind for ABT, as a considerable percentage of its revenues comes from outside the ...

The t:slim X2 pump is currently cleared for use with Humalog and Novolog/NovoRapid U-100 insulins globally, and Admelog/Insulin lispro Sanofi and Trurapi/Insulin aspart Sanofi U-100 insulins in Canada ...